HRP20221247T1 - Postupak za dobivanje 2-(5-metoksiizokroman-1-il)-4,5-dihidro-1h-imidazola i njegove hidrogensulfatne soli - Google Patents
Postupak za dobivanje 2-(5-metoksiizokroman-1-il)-4,5-dihidro-1h-imidazola i njegove hidrogensulfatne soli Download PDFInfo
- Publication number
- HRP20221247T1 HRP20221247T1 HRP20221247TT HRP20221247T HRP20221247T1 HR P20221247 T1 HRP20221247 T1 HR P20221247T1 HR P20221247T T HRP20221247T T HR P20221247TT HR P20221247 T HRP20221247 T HR P20221247T HR P20221247 T1 HRP20221247 T1 HR P20221247T1
- Authority
- HR
- Croatia
- Prior art keywords
- formula
- methoxyisochroman
- ethyl
- carboxylate
- image
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Epoxy Resins (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20176085 | 2017-12-01 | ||
| PCT/FI2018/050864 WO2019106238A1 (en) | 2017-12-01 | 2018-11-30 | Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof |
| EP18822414.1A EP3717476B1 (en) | 2017-12-01 | 2018-11-30 | Process for the preparation of 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1h-imidazole and the hydrogensulfate salt thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20221247T1 true HRP20221247T1 (hr) | 2022-12-09 |
Family
ID=64746580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20221247TT HRP20221247T1 (hr) | 2017-12-01 | 2018-11-30 | Postupak za dobivanje 2-(5-metoksiizokroman-1-il)-4,5-dihidro-1h-imidazola i njegove hidrogensulfatne soli |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11352346B2 (enExample) |
| EP (1) | EP3717476B1 (enExample) |
| JP (1) | JP7339946B2 (enExample) |
| KR (1) | KR102718536B1 (enExample) |
| CN (1) | CN111630049B (enExample) |
| AU (1) | AU2018376872B2 (enExample) |
| BR (1) | BR112020010617A2 (enExample) |
| CA (1) | CA3083734A1 (enExample) |
| DK (1) | DK3717476T3 (enExample) |
| ES (1) | ES2927193T3 (enExample) |
| HR (1) | HRP20221247T1 (enExample) |
| HU (1) | HUE059849T2 (enExample) |
| IL (1) | IL274931B2 (enExample) |
| LT (1) | LT3717476T (enExample) |
| PL (1) | PL3717476T3 (enExample) |
| PT (1) | PT3717476T (enExample) |
| SI (1) | SI3717476T1 (enExample) |
| WO (1) | WO2019106238A1 (enExample) |
| ZA (1) | ZA202003981B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021020935A1 (ko) | 2019-07-31 | 2021-02-04 | 현대자동차주식회사 | 차량 내부 네트워크에 대한 sdn 기반의 침입 대응 방법 및 이를 이용한 시스템 |
| AU2022236605A1 (en) * | 2021-03-19 | 2023-11-02 | Orion Corporation | Tasipimidine formulations and use thereof |
| JP2025502480A (ja) | 2022-01-24 | 2025-01-24 | オリオン コーポレーション | イソクロマン－イミダゾール構造のアルファ－２ａアドレナリン受容体アゴニストの新規な硫酸塩形 |
| AU2023215667A1 (en) | 2022-02-04 | 2024-09-12 | Orion Corporation | Novel salt forms of isochroman-imidazole structured alpha-2a adrenoceptor agonist |
| JP2025531623A (ja) | 2022-09-28 | 2025-09-22 | オリオン コーポレーション | タシピミジンおよびｃｙｐ２ｄ６阻害薬の併用療法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410562B1 (en) * | 1998-12-18 | 2002-06-25 | Eli Lilly And Company | Hypoglycemic imidazoline compounds |
| AR090557A1 (es) * | 2012-04-02 | 2014-11-19 | Orion Corp | DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2 |
-
2018
- 2018-11-30 KR KR1020207019100A patent/KR102718536B1/ko active Active
- 2018-11-30 AU AU2018376872A patent/AU2018376872B2/en active Active
- 2018-11-30 EP EP18822414.1A patent/EP3717476B1/en active Active
- 2018-11-30 PT PT188224141T patent/PT3717476T/pt unknown
- 2018-11-30 HR HRP20221247TT patent/HRP20221247T1/hr unknown
- 2018-11-30 PL PL18822414.1T patent/PL3717476T3/pl unknown
- 2018-11-30 ES ES18822414T patent/ES2927193T3/es active Active
- 2018-11-30 BR BR112020010617-8A patent/BR112020010617A2/pt unknown
- 2018-11-30 CA CA3083734A patent/CA3083734A1/en active Pending
- 2018-11-30 DK DK18822414.1T patent/DK3717476T3/da active
- 2018-11-30 HU HUE18822414A patent/HUE059849T2/hu unknown
- 2018-11-30 CN CN201880076883.0A patent/CN111630049B/zh active Active
- 2018-11-30 WO PCT/FI2018/050864 patent/WO2019106238A1/en not_active Ceased
- 2018-11-30 US US16/768,093 patent/US11352346B2/en active Active
- 2018-11-30 JP JP2020529522A patent/JP7339946B2/ja active Active
- 2018-11-30 IL IL274931A patent/IL274931B2/en unknown
- 2018-11-30 SI SI201830738T patent/SI3717476T1/sl unknown
- 2018-11-30 LT LTEPPCT/FI2018/050864T patent/LT3717476T/lt unknown
-
2020
- 2020-06-30 ZA ZA2020/03981A patent/ZA202003981B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL274931B2 (en) | 2023-11-01 |
| US20200308152A1 (en) | 2020-10-01 |
| RU2020121597A (ru) | 2022-01-04 |
| WO2019106238A1 (en) | 2019-06-06 |
| CN111630049B (zh) | 2023-06-20 |
| BR112020010617A2 (pt) | 2020-11-10 |
| IL274931A (en) | 2020-07-30 |
| HUE059849T2 (hu) | 2023-01-28 |
| AU2018376872A1 (en) | 2020-07-16 |
| RU2020121597A3 (enExample) | 2022-01-04 |
| CN111630049A (zh) | 2020-09-04 |
| DK3717476T3 (da) | 2022-09-05 |
| EP3717476A1 (en) | 2020-10-07 |
| JP7339946B2 (ja) | 2023-09-06 |
| KR20200095519A (ko) | 2020-08-10 |
| US11352346B2 (en) | 2022-06-07 |
| SI3717476T1 (sl) | 2022-10-28 |
| LT3717476T (lt) | 2022-09-26 |
| AU2018376872B2 (en) | 2023-12-07 |
| IL274931B1 (en) | 2023-07-01 |
| JP2021504418A (ja) | 2021-02-15 |
| ZA202003981B (en) | 2021-07-28 |
| ES2927193T3 (es) | 2022-11-03 |
| PL3717476T3 (pl) | 2022-11-21 |
| KR102718536B1 (ko) | 2024-10-21 |
| PT3717476T (pt) | 2022-08-23 |
| CA3083734A1 (en) | 2019-06-06 |
| EP3717476B1 (en) | 2022-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20221247T1 (hr) | Postupak za dobivanje 2-(5-metoksiizokroman-1-il)-4,5-dihidro-1h-imidazola i njegove hidrogensulfatne soli | |
| DK2418195T3 (en) | Agomelatinhydrogenhalogenidkompleks and manufacturing method thereof | |
| CN102367253B (zh) | 一种制备他达拉非晶型a的方法 | |
| HRP20200715T1 (hr) | Postupak proizvodnje n-[(3-aminooksetan-3-il) metil]-2-(1,1-diokso-3,5-dihidro-1,4-benzotiazepin-4-il)-6-metil-kinazolin-4-amina | |
| KR20170021256A (ko) | 축합 헤테로사이클릭 화합물의 제조 방법 | |
| RS60401B1 (sr) | Upotreba inhibitora telomeraze imetelstata za lečenje mijelodisplastičnog sindroma | |
| US9868732B2 (en) | Process of synthesizing 2-bromo-LSD | |
| JP2021504418A5 (enExample) | ||
| HRP20040287A2 (en) | Process for the preparation of citalopram | |
| ES2620660T3 (es) | Método para la fabricación de naltrexona | |
| Yalgin et al. | First examples of Doebner-Miller reaction in flow: Efficient production of 2-methylquinoline derivatives in water | |
| IN2014KN01308A (enExample) | ||
| JP2018503602A5 (enExample) | ||
| CN106674040B (zh) | 一种无溶剂无催化剂制备n-芳基酰胺的方法 | |
| US20110124866A1 (en) | Process for preparation of tadalafil | |
| US9981979B2 (en) | Process for the formation of hydrocodone bitatrate | |
| CA3132229C (en) | Process for the preparation of a substituted imidazoquinoline | |
| CN105585528A (zh) | 工业化生产西地那非酰胺中间体的合成方法 | |
| CN108976228A (zh) | 一种7-氮杂吲哚的制备方法 | |
| CN104447687B (zh) | 一种含氮七元环衍生物的工业生产方法 | |
| CN106278924B (zh) | 一种以取代米氏酸为酰化剂水相中制备n-芳基叔酰胺的方法 | |
| CN103804300A (zh) | 合成与精制离子液体[E1Mim2][NTf2]的方法 | |
| KR20220097385A (ko) | 3-니트로-n-(2,2,2-트리플루오로에틸)-4-피리딘아민의 합성 | |
| CN205501168U (zh) | Mno萃取提纯干燥装置 | |
| CN105061338A (zh) | 一种基于离子液体系的3-甲基-喹噁啉-2-羧酸化学合成方法 |